Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 1/20 | 0.64 |
| ▸ | CES1 | P23141 | 1/20 | 0.64 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.61 |
| ▸ | LMNA | P02545 | 3/20 | 0.61 |
| ▸ | P4HTM | Q9NXG6 | 2/20 | 0.61 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | GSK3B | P49841 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.47 |
| ▸ | NPC1 | O15118 | 2/20 | 0.47 |
| ▸ | RAB9A | P51151 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.46 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.46 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.46 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.46 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.46 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 2-Picolinic Acid SCHEMBL31214632 | 1.00 | CES2 (0.64) | CES2CES1L3MBTL1LMNAP4HTM | |
| 2-Picolinic Acid SCHEMBL11378795 | 0.98 | CES2 (0.67) | CES2CES1L3MBTL1LMNAP4HTM | |
| 2-Picolinic Acid SCHEMBL6054281 | 0.95 | CES2 (0.64) | CES2CES1L3MBTL1LMNAP4HTM | |
| 2-Picolinic Acid SCHEMBL2483447 | 0.95 | CES2 (0.64) | CES2CES1L3MBTL1LMNAP4HTM | |
| 2-Picolinic Acid SCHEMBL15401421 | 0.95 | CES2 (0.64) | CES2CES1L3MBTL1LMNAP4HTM | |
| 2-Picolinic Acid SCHEMBL5354659 | 0.95 | CES2 (0.64) | CES2CES1L3MBTL1LMNAP4HTM | |
| 2-Picolinic Acid SCHEMBL432467 | 0.95 | CES2 (0.64) | CES2CES1L3MBTL1LMNAP4HTM | |
| 2-Picolinic Acid SCHEMBL673572 | 0.95 | CES2 (0.64) | CES2CES1L3MBTL1LMNAP4HTM | |
| 2-Picolinic Acid SCHEMBL5058098 | 0.95 | CES2 (0.64) | CES2CES1L3MBTL1LMNAP4HTM | |
| 2-Picolinic Acid SCHEMBL11378797 | 0.95 | CES2 (0.64) | CES2CES1L3MBTL1LMNAP4HTM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 196 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025029611-A1 | THERAPIES FOR DISEASES OF COPPER METABOLISM | THE CURATORS OF THE UNIVERSITY OF MISSOURI (US) | 2025-02-06 | — | — | WO | claimed |
| EP-4187558-B1 | APPLICATION OF AN ADDITIVE IN A PREPARATION METHOD OF A SAMARIUM-COBALT 2:17 TYPE MAGNET | FUJIAN CHANGTING ZORR TECH CO LTD (CN) | 2024-07-24 | — | — | EP | claimed |
| EP-4375325-A2 | BIOCIDAL RESIN COMPOSITION INCLUDING ONE OR A PLURALITY OF RESINS SELECTED FROM MF, UF, PF, MUF AND PHENOLIC RESINS; AND MORE THAN ONE SOLUBLE COPPER SALT | COPPTECH UK LTD. (CL) | 2024-05-29 | — | — | EP | claimed |
| US-20240075043-A1 | IMMEDIATE AND CONTROLLED RELEASE APPETITE SUPPRESSANT COMPOSITIONS FOR WEIGHT LOSS | Red Mountain Med Spa, LLC (US) | 2024-03-07 | — | — | US | claimed |
| EP-4187558-A1 | ADDITIVE AND APPLICATION THEREOF, AND SAMARIUM-COBALT 2: 17 TYPE MAGNET AND PREPARATION METHOD THEREOF | Fujian Changting Zorr Technology Co., Ltd. (CN) | 2023-05-31 | — | — | EP | claimed |
| US-20220249505-A1 | APPETITE SUPPRESSANT COMPOSITIONS AND METHODS THEREOF | RED MOUNTAIN HOLDINGS, LLC (US) | 2022-08-11 | — | — | US | claimed |
| CN-114255945-A | Additive and application thereof, 2-17 type samarium-cobalt magnet and preparation method thereof | 福建省长汀卓尔科技股份有限公司 | 2022-03-29 | — | — | CN | claimed |
| CN-113582921-A | Production method of dipicolinic acid | 江西鑫海高分子材料有限公司 | 2021-11-02 | — | — | CN | claimed |
| US-20210275536-A1 | APPETITE SUPPRESSANT COMPOSITIONS AND METHODS THEREOF | RED MOUNTAIN HOLDINGS, LLC (US) | 2021-09-09 | — | — | US | claimed |
| CN-110124499-B | Treatment process for waste gas generated by recycling hazardous waste inorganic salt | 内蒙古中泰汇金环保科技有限公司 | 2021-07-30 | — | — | CN | claimed |
| US-20040105894-A1 | Trace Metals synergized copper nucleotides and copper glycosides for anti-aging and antiviral compositions | GUPTA SHYAM K (US) | 2004-06-03 | — | — | US | claimed |
| EP-1411965-A1 | METHODS AND COMPOSITIONS FOR CONTROLLING PROTEIN ASSEMBLY OR AGGREGATION | Novactyl, Inc. (US) | 2004-04-28 | — | — | EP | claimed |
| WO-2003006044-A1 | METHODS AND COMPOSITIONS FOR CONTROLLING PROTEIN ASSEMBLY OR AGGREGATION | NOVACTYL, INC. (US) | 2003-01-23 | — | — | WO | claimed |
| US-20020037908-A1 | Methods and compositions for controlling protein assembly or aggregation | NOVACTYL, INC. | 2002-03-28 | — | — | US | claimed |
| US-6043370-A | REACTING AROMATIC AMINE WITH AN AROMATIC HALIDE IN PRESENCE OF COPPER CONTAINING CATALYST IN A REACTION SOLVENT HAVING IONIZATION POTENTIAL OF FROM 8.0 TO 9.0 EV. | SANKIO CHEMICAL CO., LTD. (JP) | 2000-03-28 | — | — | US | claimed |
| CN-1139879-A | Antimicrobial method and cosmetic composition | OTSUKA PHARMA CO LTD (JP) | 1997-01-08 | — | — | CN | claimed |
| EP-0728478-A1 | ANTIMICROBIAL METHOD AND COSMETIC COMPOSITION | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1996-08-28 | — | — | EP | claimed |
| EP-0488860-B1 | Method for the production of polyalkoxylated aromatic compounds | RHONE POULENC CHIMIE (FR) | 1995-10-11 | — | — | EP | claimed |
| EP-0423010-B1 | METHOD FOR THE PRODUCTION OF ALKOXYBENZALDEHYDES | RHONE-POULENC CHIMIE (FR) | 1993-09-29 | — | — | EP | claimed |
| US-RE33988-E | Dietary supplementation with essential metal picolinates | The United States of America as repesented by the Secretary of Agriculture (US) | 1992-07-07 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020037908-A1 | Methods and compositions for controlling protein assembly or aggregation | PSEN1, PSEN2, PRNP | CES2 4028/4885CES1 4539/4885L3MBTL1 4530/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.